Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms

Published:2021-06-07 Issue:21 Volume:27 Page:2895-2909
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Han Deng,Li Yuan-Liang,Zhou Zhi-Wei,Yin Fei,Chen Jie,Liu Fang,Shi Yan-Fen,Wang Wei,Zhang Yu,Yu Xian-Jun,Xu Jian-Ming,Yang Run-Xiang,Tian Chao,Luo Jie,Tan Huang-Ying

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference28 articles.

1. Update on gastroenteropancreatic neuroendocrine tumors

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival

4. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research

5. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of gastric neuroendocrine tumors and the PDX-1 transcription factor expression;Russian Journal of Archive of Patology;2024

2. Deep learning radiomics analysis based on computed tomography for survival prediction in gastric neuroendocrine neoplasm: a multicenter study;Quantitative Imaging in Medicine and Surgery;2023-12

3. Endoscopic features of gastric neuroendocrine carcinoma;Journal of Gastroenterology and Hepatology;2023-08

4. Solitary metachronous adrenal metastasis after radical resection of gastric large cell neuroendocrine carcinoma: a case report and literature review;Journal of International Medical Research;2023-04

5. Prognosis of patients with poorly differentiated gastric neuroendocrine neoplasms: a multi-center study in China;Future Oncology;2022-07